The ENHANCE Phase 3b clinical trial is evaluating the safety and efficacy of a modified treatment regimen of Briumvi for ...

MS patients in the U.S. with Medicaid coverage have worse disease outcomes compared with those who have private insurance, a ...

Multiple sclerosis (MS) is a chronic disease of the central nervous system that is thought to be an autoimmune disorder where ...

For Pree, diagnosed with multiple sclerosis at 19, finishing college was a challenge. Still, amidst it all, she decided to open up about her journey by sharing her first video on YouTube. Little did ...

Data from an open-label extension of VISIONARY-MS support an association between gold nanocrystals and neuronal repair and remyelination in patients with stable multiple sclerosis and visual deficits, ...

Depression and anxiety have been well documented in people with multiple sclerosis (MS), but often are undiagnosed or ...

That's because Greg, an engineer, rode his bike in the MS 150, a punishing ride, formerly between Houston and Austin. (The ...

Tolebrutinib slows disability progression in adults with nonrelapsing secondary progressive multiple sclerosis (MS).

Octave Bioscience, Inc., a leading precision care company that delivers a new standard for managing multiple sclerosis (MS) ...

Researchers from the Netherlands Institute for Neuroscience (NIN) have discovered new potential therapeutic targets for ...

Hauser's work on multiple sclerosis (MS) started more than 45 years ago, when he met a young patient named Andrea, "an ...

New research led by a St. Michael's Hospital clinician-scientist and published in the New England Journal of Medicine ...